<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00520962</url>
  </required_header>
  <id_info>
    <org_study_id>199402-1369/516</org_study_id>
    <nct_id>NCT00520962</nct_id>
  </id_info>
  <brief_title>Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk</brief_title>
  <official_title>New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at
      high risk to develop alterations of glucose metabolism and definition of new pathogenic
      mechanisms of insulin resistance and atherosclerosis.

      The following classes of subjects at high risk will be considered:First degree relatives of
      patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke,
      patients with heart valve disease. age will be &gt; 30 years, both gender.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary outcome of the study is evaluation of glucose tolerance, insulin sensitivity and
      insulin secretion before and 2 hours post-glucose load Secondary outcomes are evaluation of
      endothelial function, of natriuretic peptides and free fatty acids, and inflammation before
      and 2 hours post-glucose load. New candidate genes will be also evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 1997</start_date>
  <completion_date type="Actual">May 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Cross-Sectional, Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1997</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>1,2,3</arm_group_label>
    <arm_group_type>Case</arm_group_type>
    <description>First degree relatives of patients with type 2 diabetes
Patients with cardiovascular disease and stroke
patients with heart valve disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Control</arm_group_type>
    <description>Healthy controls</description>
  </arm_group>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fasting glucose levels &lt;126 mg/dl

          -  Age &gt;30 years

          -  Both male and female

        Exclusion Criteria:

          -  Type 1 diabetes

          -  Known type 2 diabetes mellitus

          -  Pregnancy

          -  Impaired kidney and liver function

          -  Previous history of malignancies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PierMarco Piatti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCSS San Raffaele</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medicine Division, Diabetology, Endocrinology and Metabolic Disease Unit, IRCCS San Raffaele</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2007</study_first_submitted>
  <study_first_submitted_qc>August 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2007</study_first_posted>
  <last_update_submitted>August 24, 2007</last_update_submitted>
  <last_update_submitted_qc>August 24, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2007</last_update_posted>
  <keyword>cardiovascular disease</keyword>
  <keyword>glucose intolerance</keyword>
  <keyword>type 2 diabetes</keyword>
  <keyword>endothelial dysfunction</keyword>
  <keyword>inflammation</keyword>
  <keyword>Age&gt; 30 years, male and female</keyword>
  <keyword>Fasting glucose below 126 mg/dl</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

